ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 81 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $35,961 | +11.6% | 6,309 | +15.3% | 0.00% | – |
| Q4 2022 | $32,236 | -25.0% | 5,473 | -59.6% | 0.00% | – |
| Q3 2022 | $43,000 | -28.3% | 13,563 | +1.1% | 0.00% | – |
| Q2 2022 | $60,000 | -85.1% | 13,416 | -82.3% | 0.00% | -100.0% |
| Q1 2022 | $404,000 | +797.8% | 75,599 | +3424.4% | 0.00% | +200.0% |
| Q3 2021 | $45,000 | -76.9% | 2,145 | -80.5% | 0.00% | -50.0% |
| Q2 2021 | $195,000 | +490.9% | 11,024 | +716.6% | 0.00% | – |
| Q1 2021 | $33,000 | -90.8% | 1,350 | -87.3% | 0.00% | -100.0% |
| Q2 2020 | $357,000 | – | 10,598 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $4,673,631 | 14.75% |
| Nextech Invest Ltd. | 4,285,714 | $33,257,141 | 11.30% |
| Column Group LLC | 3,568,181 | $27,689,085 | 10.75% |
| Prosight Management, LP | 5,522,936 | $42,857,984 | 6.42% |
| Invus Financial Advisors, LLC | 1,007,575 | $7,818,782 | 4.18% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,450,822 | $11,258,379 | 3.48% |
| VR Adviser, LLC | 2,142,856 | $16,628,563 | 2.66% |
| Euclidean Capital LLC | 747,550 | $5,800,988 | 1.49% |
| Frazier Life Sciences Management, L.P. | 2,142,855 | $16,628,555 | 0.99% |
| Monaco Asset Management SAM | 378,222 | $2,935,003 | 0.82% |